Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06460038
PHASE2

Tenapanor in Synucleinopathy-Related Constipation

Sponsor: Cedar Valley Digestive Health Center

View on ClinicalTrials.gov

Summary

Investigation of tenapanor as a potential treatment for synucleinopathy-associated constipation

Official title: Efficacy and Safety of Tenapanor in Synucleinopathy-Related Constipation

Key Details

Gender

All

Age Range

50 Years - 89 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-01-01

Completion Date

2027-03

Last Updated

2025-02-10

Healthy Volunteers

No

Interventions

DRUG

Tenapanor

Inhibitor of NHE3

DRUG

Placebo

Placebo drug

Locations (1)

Cedar Valley Digestive Health Center

Waterloo, Iowa, United States